Skip to content

Clinical trials

Phase 3 Acute Kidney Injury trials in the United States

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Acute Kidney Injury Phase: Phase 3 Country / region: United States Clear all

19 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20032
20051
20081
20131
20151
20162
20171
20182
20191
20201
20211
20221
20232
20241
20251

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed7
Terminated4
Unknown status4
Recruiting3
Withdrawn1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
US Department of Veterans Affairs2
University of Alabama at Birmingham2
Vantive Health LLC2
Alexion Pharmaceuticals, Inc.1
Angion Biomedica Corp1
Atox Bio Ltd1
Brigham and Women's Hospital1
Ejaz, Abulate A, MD1
Fresenius Medical Care North America1
Le Bonheur Children's Hospital1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Acute Kidney Injury19
Kidney Diseases2
Thrombotic Microangiopathies2
COVID-191
Cardiovascular Diseases1
Coronary Artery Disease1
Critical Illness1
Death1
Delayed Graft Function1
Diabetes Mellitus, Type 21

Trials

Showing 1 to 19 of 19. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.